Hair transplants for women: who is a candidate, and what women reported

Yes, women can have a hair transplant, but fewer women than men are good candidates. This page puts two things side by side: what dermatology reviews, studies and the surgeons’ society say (15 sources, quoted at the bottom), and what women who had one wrote on reddit about their own transplant with doctors in our directory: the grafts they had, the technique, and what they paid.

In short: a transplant moves hair from the back of the head, so it works when that donor hair is dense and the loss has stabilised, for example thinning at the front, or temples thinned by tight hairstyles. It works poorly when hair is thin everywhere, including the back. Other causes of hair loss (thyroid, PCOS, scarring conditions) need to be ruled out first. Women more often get the strip method (FUT), because it doesn’t need shaving, and they are more prone to temporary shedding of their existing hair after surgery. Among the 90 women in our patient reports, the typical transplant was smaller than men’s, and 51% of those who named their technique had strip surgery.

Can women get a hair transplant?

Women and men of all races can be candidates, as long as there is enough donor hair and the thinning area can still grow hair [10]. The catch is the pattern. Female pattern hair loss is usually diffuse: the part widens, the top and crown thin while the front hairline stays, or the front thins in a triangle (“Christmas tree”) shape; women rarely go fully bald [2][3]. Women also tend to come later than men, with thinning across the top and temples rather than the receding front and crown typical in men [1]. If the hair is thin all over, there may not be enough healthy hair to move [3].

A review in the International Journal of Women’s Dermatology describes the ideal female candidate as someone with dense donor hair at the back, marked thinning at the front, and hair loss that has stabilised and not responded to medication [2]. Transplants also work for traction alopecia, the hair loss from tight hairstyles that mostly hits the temples [6].

It is less rare than it sounds: in 2024 about 15% of the surgical procedures by members of the International Society of Hair Restoration Surgery (ISHRS) were on women, and about a fifth of those were not on the scalp at all, mostly eyebrows [5]. Demand from women has been growing [1].

Rule out other causes first

Several conditions look like female pattern hair loss, so they need to be ruled out before anyone plans surgery [3]. Hormonal causes include thyroid disorders and PCOS [4], and a blood test may be needed to find the cause [10]. Reviews say women should also be checked for scarring or traction hair loss [1]. The common causes, how each looks and the tests: hair loss in women.

Scarring conditions matter most. Active inflammatory or scarring alopecia rules a transplant out; it has to be quiet on treatment for 9 to 12 months, confirmed by biopsy, first [6]. Even then, results fade: in a 2026 review of 113 patients with lichen planopilaris or frontal fibrosing alopecia (two scarring conditions that mostly affect women), grafts mostly survived well for a year or two, then usually fell below 41% survival after the second year [7]. People prone to keloid scars, which are more common in skin of color, should have that checked before surgery [6].

How a transplant differs for women

The donor area. In women the back of the head often thins too, so the donor hair has to be checked carefully [4]. A limited donor area, placing grafts between existing hairs, and a temporary worsening after surgery are the usual problems in women [2].

Strip (FUT) or FUE. Women tend to prefer the strip method because it spares the donor area and suits long hair [1]. FUT doesn’t need the donor area shaved; FUE is often done with shaving, though no-shave options exist, and FUE in a woman with diffuse thinning can thin an already thin donor area further [4]. ISHRS members used strip harvesting in 30% of women’s procedures, against 12.5% of men’s [5]. A Brazilian surgeon who reviewed 751 women he treated with FUT over 31 years favours it because the recipient area need not be shaved and surgery is shorter than FUE [11].

The hairline. A female hairline is designed softer and rounder than a man’s [4].

Size. In a study of 195 Korean women, on average about 3,000 hairs were placed with FUT and 2,600 with FUE [8]; that study counted hairs, not grafts, so the graft count was lower. In our patient reports below, women had fewer grafts than men.

A high hairline: lowering surgery or a transplant

For a high forehead with otherwise good hair, there is a second option: hairline lowering (forehead reduction) surgery. In one surgeon’s series of 29 women, the hairline moved forward 2.1 cm on average; unlike a transplant the result is immediate, but it leaves an incision line at the hairline [12]. A 2026 meta-analysis of 14 studies (3,213 patients, mostly women) found complications in about 6%, temporary numbness in nearly everyone, and 1.2% who later had a transplant as well [13]. One of the women in our patient reports had a transplant to camouflage the scar of an earlier hairline lowering.

Medication alongside a transplant

Hair loss can continue after a transplant, so medication may be advised as well [10]; in the Brazilian FUT series, 18% of women came back for a second procedure, on average 4 years later, because their hair loss kept progressing [11].

  • Minoxidil is FDA-approved for women without a prescription, in 2% and 5% strengths, and is the most recommended treatment [3]. The women’s 5% foam is used once a day, and results can take 3 months, or at least 6 for some women [14]. Women who are pregnant, planning pregnancy or breastfeeding should avoid it [3]. More: how to use minoxidil.
  • Finasteride is not approved for women, must not be used by women who are or may become pregnant, and in a 12-month trial in 137 postmenopausal women it did no better than placebo [15].
  • Spironolactone is used off-label as an anti-androgen for female pattern hair loss [2]. More: spironolactone and hair loss.

Shock loss and when results show

Shock loss is shedding of your existing hair around the new grafts, usually 2 to 8 weeks after surgery, with regrowth from about 3 months. Female sex is a major risk factor; it is usually temporary, but some hair that was already thinning may not come back [9]. In the Korean study, 45% of the women shed existing hair in the transplanted area and 7% around the donor site; 88% rated their satisfaction at 75% or more [8].

The transplanted hairs themselves fall out 2 to 8 weeks after surgery, so by month 3 hair can look thinner than before; most people see results at 6 to 9 months, some at 12 [10]. A touch-up should wait until final growth, around 12 months [9]. Month by month from patients’ own reports: recovery timeline and shock loss.

What women wrote about their own transplant

Of the people in our doctor directory’s patient reports who said they are a woman, 90 had a transplant or had booked one with one of 49 listed doctors, and 42 more wrote while still choosing. Each woman counts once, however many threads she wrote. Most people never say their gender, so the real number of women among these patients is higher.

Fewer grafts than men. The middle half of the women who gave a graft count had 1,503 to 3,055 grafts (median 2,300, 60 women). For men who said they are men, it was 2,200 to 3,800 (median 2,926, 888 men).

Women in these reports chose strip surgery (FUT) far more often. Of the women who named their technique, 20 had FUT and 19 had FUE or DHI (51% FUT). Among men it was 55 FUT to 384 FUE or DHI (13% FUT). FUT takes a strip from the back of the head, so the rest of the hair can stay long; FUE often means shaving the donor area. The ISHRS survey points the same way, though less starkly (30% of women’s procedures vs 12.5% of men’s [5]); people who name their technique on reddit are not a random sample.

Women 51% FUT
Men 13% FUT

Doctors women went to

Doctors in our directory with at least one woman who wrote about her own transplant with them, most first. A high number reflects how many women write on reddit about a doctor, not quality; read their reports.

DoctorCountryHad it done or bookedWomen choosing
John Diep Medical Hair Transplant & Aesthetics (MHTA)US91
Pukpinya Jangjetriew Hairtran ClinicThailand81
Kaan Pekiner PHR ClinicTurkey62
Ron Shapiro Shapiro Medical GroupUS41
Sean Behnam Dermatology & Hair Restoration Specialists (site branded Hair Restoration Los Angeles - Dr. Sean Behnam, igethair.com)US32
Ratchathorn Panchaprateep Absolute Hair ClinicThailand31
Kongkiat Laorwong Absolute Hair ClinicThailand3
Rafael De Freitas Clínica de FreitasSpain3
Sibel Ulusan Dr. Ulusan ClinicTurkey3
Damkerng Pathomvanich DHT ClinicThailand21
Dogan Turan FUECAPILARTurkey21
Jerry Wong Hasson & Wong Hair Transplant ClinicCanada21
Victor Hasson Hasson & Wong Hair Transplant ClinicCanada21
Bekir Bek Dr. Bekir Bek Hair TransplantTurkey2
Edward Ball The Maitland ClinicUK2
Hakan Doganay AHD Clinic (AHD Hair Transplant Clinic / legally AHD Polikliniği)Turkey2
Ibrahim Jebai Jay ClinicsLebanon2
Ozlem Bicer Dr. Özlem Biçer Hair Transplant ClinicTurkey2
Bijan Feriduni Dr. Feriduni Hair ClinicBelgium13
Christian Bisanga BHR ClinicBelgium13
Jorge Cortez Hair Medical Restoration (HMR)Mexico13
Sahar Nadimi Chicago Hair InstituteUS13
Espinosa Custodio Instituto Médico del Prado (Dr. Espinosa Custodio clinic)Spain12
Luis Nader Nader MedicalMexico11
Parsa Mohebi Parsa Mohebi Hair RestorationUS11
Sergio Camacho Bogota HairlinesColombia11
Steven Gabel Gabel Hair Restoration Center (Gabel Center)US11
Alfonso Barrera West Houston Plastic SurgeryUS1
Aron Nusbaum Miami Hair InstituteUS1
Arthur Katona Advanced Hair Restoration (Atlanta office)US1
Bernardino Arocha Arocha Hair RestorationUS1
Blake Bloxham Bloxham Medical (formerly Feller & Bloxham Hair Transplantation)US1
Carlos Wesley Carlos K. Wesley, MD PCUS1
Christina Vryonidou HDC Hair Clinic (HDC Hair Transplant Centre)Cyprus1
David Josephitis Shapiro Medical GroupUS1
Gokhan Gür FUECAPILARTurkey1
Henrique Machado HM ClinicPortugal1
Jae Pak Jae Pak MD MedicalUS1
Jean Luc Portelli St Mary's Hair Clinic (St Mary's Clinic)Malta1
Jeffrey S. Epstein Foundation Aesthetic Hair Restoration (formerly The Foundation for Hair Restoration; also branded Dr. Jeffrey Epstein, MD FACS)US1
Jennifer Krejci Limmer Hair Transplant CenterUS1
Juan Couto FUExpert ClinicSpain1
Ken Anderson Anderson Center for HairUS1
Munib Ahmad FueGenixNetherlands1
Paola Pareja Bogota HairlinesColombia1
Prima Tossaborvorn Hairsmith ClinicThailand1
Robert Bernstein Bernstein Medical - Center for Hair RestorationUS1
Servet Terziler Dr. Terziler Exclusive ClinicTurkey1
William Lindsey Lindsey Medical, PCUS1

Women also asked about: Marc Dauer, Raymond Konior, Tsvetalin Zarev, Abdul Muttalip Keser, Arika Bansal, Bob True, H. Rahal, Koray Erdogan, Manish Mittal, Martin Zadnik, Russell Knudsen, Sever Muresanu, Taleb Barghouthi, Thiago Bianco Leal.

What women said they paid

33 women gave both the price they paid and their graft count. Prices as they reported them, in their currency, newest first; the per-graft figure is simply the price divided by the grafts. Clinic prices change, so check the doctor’s profile for the current published price or a recent quote.

YearDoctorGraftsPaidPer graft
2026Edward Ball · UK1,409GBP 7,750GBP 5.50
2026Kongkiat Laorwong · Thailand1,400THB 176,000THB 126
2026Arthur Katona · US2,071USD 10,000USD 4.83
2025Pukpinya Jangjetriew · Thailand2,229USD 3,516USD 1.58
2025Pukpinya Jangjetriew · Thailand2,500THB 110,000THB 44
2025Kaan Pekiner · Turkey1,429USD 7,000USD 4.90
2025Bekir Bek · Turkey3,928EUR 7,856EUR 2.00
2025Pukpinya Jangjetriew · Thailand3,365AUD 6,000AUD 1.78
2025Dogan Turan · Turkey1,800EUR 4,500EUR 2.50
2025Ratchathorn Panchaprateep · Thailand3,574USD 10,300USD 2.88
2024Kaan Pekiner · Turkey900EUR 3,200EUR 3.56
2024Ratchathorn Panchaprateep · Thailand3,248USD 8,800USD 2.71
2024Kongkiat Laorwong · Thailand3,500USD 6,500USD 1.86
2024Damkerng Pathomvanich · Thailand2,951AUD 10,000AUD 3.39
2024Juan Couto · Spain1,400EUR 5,600EUR 4.00
2024Carlos Wesley · US2,400USD 19,230USD 8.01
2024Hakan Doganay · Turkey4,200USD 4,350USD 1.04
2024Ibrahim Jebai · Lebanon2,000USD 3,500USD 1.75
2024Dogan Turan · Turkey1,463EUR 3,600EUR 2.46
2024Jean Luc Portelli · Malta4,600EUR 3,300EUR 0.72
2023John Diep · US1,300USD 12,600USD 9.69
2023Sean Behnam · US5,100USD 25,000USD 4.90
2023Sahar Nadimi · US1,500USD 13,500USD 9.00
2023Espinosa Custodio · Spain1,378EUR 4,134EUR 3.00
2023Pukpinya Jangjetriew · Thailand2,500THB 112,000THB 45
2023Henrique Machado · Portugal2,500EUR 3,450EUR 1.38
2022Rafael De Freitas · Spain2,423EUR 6,900EUR 2.85
2022Aron Nusbaum · US2,800USD 14,000USD 5.00
2022Jeffrey S. Epstein · US1,200USD 10,800USD 9.00
2022Pukpinya Jangjetriew · Thailand3,058THB 111,000THB 36
2021John Diep · US2,005USD 11,000USD 5.49
John Diep · US2,832USD 12,000USD 4.24
Sean Behnam · US2,500USD 18,500USD 7.40

Women’s own reports

The 18 most detailed: one card per woman, summarised from what she wrote, with a link to each of her threads. More are on each doctor’s profile.

The sources

[1] Hair Transplantation in Women

Queen D, Avram MR · Journal of Drugs in Dermatology 24(9):851-855, 2025 · A literature review: the authors screened 1,443 PubMed records and analysed 24 studies on hair transplantation in women. Abstract only (full text is paywalled), so the details and strength of the underlying studies could not be checked. No conflict-of-interest statement in the abstract.

  • Women tend to come for a transplant later than men, and usually have diffuse thinning over the crown and temples rather than the localized front and crown recession men have. “Women often present later than men for transplantation, with diffuse thinning across the vertex and temples compared to men who typically present with localized frontotemporal and crown recession.”
  • Before surgery, women should be checked for other body-wide causes and for scarring or traction hair loss. “Women should be evaluated for systemic contributors and the presence of scarring or traction alopecia.”
  • Women tend to prefer the strip method (FUT) because it spares the donor area and suits long hair. “Women favor follicular unit transplantation (FUT) due to donor area preservation and compatibility with long hairstyles”
  • The review says demand from women has been growing. “with increasing demand from women in recent years”

[2] Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review

Fabbrocini G, Cantelli M, Masarà A, Annunziata MC, Marasca C, Cacciapuoti S · International Journal of Women's Dermatology 4(4):203-211, 2018 · A narrative review by dermatologists (University of Naples) of how female pattern hair loss looks, how it is diagnosed and treated, including a short section on transplantation. It summarises other work and adds no new patient data. Funding: none; authors declare no competing interests.

  • Female pattern hair loss is a non-scarring, diffuse loss, mostly over the central, front and side areas of the scalp. “FPHL is characterized as a nonscarring diffuse alopecia that evolves from the progressive miniaturization of hair follicles and subsequent reduction in the number of hairs, especially in the central, frontal, and parietal scalp regions”
  • One common form is thinning at the top and crown with the front hairline kept; another is a triangular 'Christmas tree' pattern at the front (Olsen). “The first manifestation is the diffuse thinning of the upper biparietal and vertex regions and preservation of the anterior hair implantation line.”
  • The ideal female transplant candidate has dense donor hair at the back and marked thinning at the front, with loss that has stabilised and not responded to medication. “Ideal surgical candidates for hair transplantation are women with high hair density in the donor site over the occipital scalp and extensive hair loss or thinning of the frontal scalp.”
  • The usual problems in women are a limited donor area, having to place grafts between existing hairs, and a temporary worsening after surgery. “The most common problems that are encountered in hair transplantation in women are related to insufficient hair donor areas, the need for magnification to insert the grafts between the existing hair follicles in the recipient area, and temporary worsening of global aspect after the transplant.”
  • Spironolactone is used off-label as an anti-androgen for female pattern hair loss. “Spironolactone is the most commonly used, off-label anti-androgen for the treatment of female AGA and hirsutism.”

[3] Thinning hair and hair loss: Could it be female pattern hair loss?

American Academy of Dermatology (no named author) · American Academy of Dermatology (aad.org), patient information · A patient information page from the American Academy of Dermatology, the US dermatologists' professional body. It is general guidance, not a study, and states no publication or review date on the archived page.

  • Not every woman is a candidate: if hair is thin all over, there may not be enough healthy hair to move. “If the hair on your scalp is sparse all over, you may not have enough healthy hair to transplant.”
  • Other conditions can look like female pattern hair loss, so they need to be ruled out first. “Other causes of hair loss can look like FPHL, so it’s important to rule out these causes.”
  • In women the parting usually widens and the temples may recede; women rarely go fully bald. “But women do not lose all of their hair, as do some men. Instead, your part often gets wider. Hair near your temples may recede.”
  • Minoxidil is FDA-approved for women without a prescription, in 2% and 5% strengths, and is the most recommended treatment. “Products containing either 2% or 5% minoxidil have been approved to treat FPHL.”
  • Women who are pregnant, planning pregnancy or breastfeeding should avoid minoxidil. “Women who are pregnant, plan to become pregnant, or who are breastfeeding should avoid minoxidil.”

[4] A Guide to Hair Transplant for Women

ISHRS Editorial Staff (first-person expert sections and photos credited to Dr. Linkov) · International Society of Hair Restoration Surgery (ishrs.org), patient information, 2025 · A patient guide from the International Society of Hair Restoration Surgery, published 23 Apr 2025 and modified 23 Apr 2026 per the page metadata. It is expert opinion, not a study; the society represents transplant surgeons and the page ends with a link to find a member surgeon, so it has an interest in promoting surgery.

  • Women can lose hair from hormonal changes, including thyroid disorders and PCOS. “Women frequently encounter hormonal fluctuations due to pregnancy, menopause, thyroid disorders, or polycystic ovary syndrome (PCOS).”
  • Women often thin in the donor area too, so donor hair has to be checked carefully. “Women frequently have diffuse thinning even in traditional donor areas, requiring a meticulous assessment of follicle viability.”
  • FUT (strip) does not need the donor area shaved, which women usually prefer; FUE is often done with shaving, though no-shave options exist. “No need to shave the donor area which is typically favored by women.”
  • FUE in a woman with diffuse thinning can thin an already thin donor area further. “Further global thinning of an already thin donor area, which can affect the appearance and styling options for patients.”
  • Female hairlines are designed softer and rounder than men's. “Female hairlines typically follow a softer, rounded contour, unlike the sharp, angular hairlines frequently desired by male patients.”

[5] 2025 ISHRS Practice Census Results

Relevant Research Consulting for the ISHRS · International Society of Hair Restoration Surgery, 2025 · An online survey of ISHRS member physicians about their 2024 practice, run by an independent survey firm: 247 of 946 members responded (26%), stated margin of error +/- 5.4%. Figures are members' own estimates, weighted by region; it covers ISHRS members only, not all clinics worldwide. Commissioned by the surgeons' society.

  • 247 of 946 members answered, a 26% response rate. “Of the 946 physician members with valid e-mails, 247 responses were received by the February 14, 2025, deadline, representing a 26 percent response rate.”
  • In 2024 about 15% of surgical hair restoration procedures by ISHRS members were on women. “On average, 84.7 percent of procedures were performed on men, while 15.3 percent were performed on women.”
  • Women more often got the strip method than men: 30% strip vs 68% FUE for women, against 12.5% strip for men. “followed by ‘Hair Transplantation with strip/linear harvesting’ (males: 12.5%, females: 30.0%)”
  • About 21% of women's procedures were not on the scalp, eyebrows being the most common. “Among women, 21 percent of procedures targeted non-scalp areas of the body with eyebrow being the most common non-scalp target area (12.2%)”

[6] Current and emerging treatment strategies for hair loss in women of color

Okereke UR, Simmons A, Callender VD · International Journal of Women's Dermatology 5(1):37-45, 2019 · A narrative review by US dermatologists (Callender Dermatology) of hair loss types in women of color and their medical and surgical treatment. It summarises other work; no new patient data. Authors declare no conflicts of interest; the review shows named commercial FUE devices in its figures.

  • Transplantation works for women of color with female pattern hair loss and traction alopecia, and may be considered in stable central centrifugal cicatricial alopecia. “Hair transplantation is an effective surgical treatment for women of color with FPHL, TA, and may also be considered in patients with stable CCCA as determined by clinical and histologic evaluations.”
  • Traction alopecia comes from tight hairstyles and most often hits the temples. “The most commonly involved area is the bitemporal region”
  • Active inflammatory or scarring alopecia is a contraindication; it must be quiet on treatment for 9-12 months and confirmed by biopsy first. “Disease must be quiescent on medical therapy for 9 to 12 months, and confirmed with biopsy test results before hair transplantation can be considered.”
  • Keloid scarring, more common in skin of color, should be checked before surgery. “Contraindications for hair transplantation are similar in all racial groups, and includes keloids scarring of which patients of color have a higher incidence.”

[7] Systematic review of efficacy of hair transplantation in patients with classic lichen planopilaris and frontal fibrosing alopecia: revisiting the current evidence

Palacios-Diaz RD, Lasheras-Pérez MA · Anais Brasileiros de Dermatologia, 2026 · A systematic review of 13 published studies (113 patients) of hair transplants in lichen planopilaris and frontal fibrosing alopecia, scarring conditions that mostly affect women. All are case series or case reports, with no trials and inconsistent follow-up, so the numbers are rough. No funding; no conflicts declared.

  • The evidence is 13 small studies with 113 patients, about two-thirds with frontal fibrosing alopecia. “The authors included thirteen studies (113 patients): eight were case series (61.5%) and five articles were individual case reports (38.5%). 64.8% patients had frontal fibrosing alopecia, while 35.2% had the classic subtype.”
  • Grafts usually survived well in the first year or two but mostly dropped below 41% survival after the second year. “In most cases, survival rates were between from 80%‒100% at 6‒12 months, 71%‒100% up to 24-months, and below 41% after the second year.”
  • Conclusion: a transplant can be considered cosmetically, but graft survival clearly declines after two years. “However, a clear decline in graft survival rate was noted after the second year.”
  • No trials exist; the data are heterogeneous. “No prospective studies or clinical trials were identified.”

[8] Clinical Features of Patients Treated With Hair Transplants in Female Pattern Hair Loss

Yun D, Kim D, Juhyun C, Yeom K, Kim MH, Choi MS, Park G, Park JH, Ahn J, Jung J, Cho H, Hwang S, Park BC · Annals of Dermatology 36(6):358-364, 2024 · A retrospective chart review of 195 Korean women with female pattern hair loss who had transplants at six South Korean centres between 2010 and 2020. No control group; satisfaction was self-rated at least a year after surgery. Most had FUT (75%). Funding: none; authors have nothing to disclose.

  • The women were 49 years old on average, mostly mild to moderate loss. “The mean (±SD) age of patients was 49.1±11.9 years.”
  • On average 3,034 hairs were implanted with FUT and 2,621 with FUE (hairs, not grafts: the study counted follicular units x2). “The mean implanted hair numbers were 3,034±687.7 in FUT and 2,621±628.4 in FUE”
  • 88% rated their satisfaction at 75% or more; those with more hairs implanted were more satisfied. “88.2% of patients had more than 75% satisfaction with HT. The satisfaction level was significantly higher in the group that had the highest number of hairs implanted.”
  • 45% had shock loss of their existing hair in the transplanted area, and 7% around the donor site. “Furthermore, 6.7% and 45.1% of patients experienced telogen effluvium of surrounding hair at the donor site and of preexisting (not transplanted) hair at the recipient site, respectively.”
  • Recovery from shedding generally begins about 3 months after surgery, when the transplanted follicles start growing. “Recovery from recipient-site effluvium generally begins approximately 3 months after HT, when the transplanted follicles begin their new growth cycle”

[9] Complications in follicular unit excision hair transplantation: current evidence and practical approaches

Romera de Blas C, Vega Díez D, Ricart Vayá JM, Gómez Zubiaur A · Frontiers in Medicine, 2026 · A narrative review of FUE complications by Spanish dermatologists (PubMed and Embase to Sept 2025). It summarises other studies rather than pooling them, so incidence ranges are as reported elsewhere. No funding; no conflicts declared.

  • Shock loss is temporary shedding of native hair around the grafts, usually 2-8 weeks after surgery, regrowing from about 3 months. “It typically occurs within 2–8 weeks after surgery, with regrowth usually beginning around 3 months postoperatively.”
  • Reported shock loss rates vary from 0.15% to 15%. “Reported incidence varies widely, ranging from 0.15 to 15% (70).”
  • Female sex is a major risk factor for shock loss, and older age adds to it in women with female pattern hair loss. “Female sex has been identified as a major risk factor, with older age further increasing susceptibility among women with female pattern hair loss (FPHL) (70).”
  • Shock loss is usually temporary, but some already-miniaturised hair may not come back. “Although typically temporary, a permanent reduction in native hair density may occur, particularly in follicles nearing the end of their growth cycle or already miniaturized (12).”
  • Touch-up procedures should wait until final growth, usually around 12 months. “Secondary procedures or touch-up sessions should only be considered once final growth is achieved, typically around 12 months after surgery (12).”

[10] A hair transplant can give you permanent, natural-looking results

American Academy of Dermatology (no named author) · American Academy of Dermatology (aad.org), patient information · A patient information page from the American Academy of Dermatology. General guidance, not a study; no date shown on the archived page.

  • Men and women of all races can be candidates; you need enough donor hair and a thinning area that can still grow hair. “Men and women of all races can be good candidates for a hair transplant.”
  • A blood test may be needed to find the cause of the hair loss. “To find out why you have hair loss, you may also need a blood test.”
  • Most see results at 6-9 months; for some it takes 12 months. “Most patients see results between six and nine months after surgery. For some patients, it takes 12 months.”
  • The transplanted hair falls out 2-8 weeks after surgery, and by month 3 hair may look thinner than before; this is normal. “By the third month, the hair may look thinner than before you had the transplant.”
  • Medication may be advised because hair loss can continue after a transplant. “Medicine helps because hair loss and thinning can continue, even after a hair transplant.”

[11] Female Pattern Hair Loss: Why the Follicular Unit Transplantation Surgical Technique Remains a Good Option

Uebel CO, Piccinini PS, Spencer LSB, da Silveira JAM · Plastic and Reconstructive Surgery 147(4):839-849, 2021 · One Brazilian surgeon's retrospective review of his own 751 women with female pattern hair loss treated with FUT over 31 years (level IV evidence, no comparison group). Abstract only. The authors report no financial disclosures and no funding; the senior author's own practice is the subject.

  • 751 women had FUT over 31 years; average age 48. “A total of 751 patients with female pattern hair loss underwent follicular unit transplantation over the past 31 years. Average patient age was 48 years.”
  • 18% came back for a second procedure, on average 4 years later, because the hair loss kept progressing. “One hundred thirty-five patients (18 percent) underwent a second replacement, at an average period of 4 years after the procedure, because of the progressive nature of female pattern hair loss.”
  • The authors favour FUT for women because the recipient area need not be shaved and surgery is shorter than FUE. “there is no need to shave the recipient sites, operative times are shorter than for follicular unit excision techniques”
  • Reported complications: donor scar widening in 6 and folliculitis in 17 patients. “Complications included donor-site scar widening in six patients and folliculitis in 17 patients.”

[12] Correction of the high female hairline

Ramirez AL, Ende KH, Kabaker SS · Archives of Facial Plastic Surgery 11(2):84-90, 2009 · A retrospective review of 29 women who had surgical hairline lowering (scalp advancement) by one surgeon, the senior author, measured on photographs. Abstract only; no comparison with transplantation and no conflict statement in the abstract.

  • 29 women had hairline lowering by the same surgeon. “A retrospective review of 29 female patients who underwent the hairline-lowering procedure performed by the same surgeon (S.S.K.).”
  • The hairline moved forward by 2.1 cm on average, measured on profile views. “The average advancement was 2.1 cm in this study.”
  • There were three complications: two cases of shedding and one scar revision. “Three complications occurred, including 1 major effluvium, 1 minor effluvium, and 1 scar that required revision.”
  • Unlike a transplant, the result is immediate, but it leaves an incision line at the hairline. “The technique is immediately effective, well tolerated by patients, and associated with minimal complications. Although it is associated with a potentially visible incision”

[13] Forehead Length Reduction Surgery: Quantifying Complications and Outcomes Through Systematic Review and Meta-Analysis

Alabdulkarim A, Halawani IR, Alghamdi AM, Alobaidy SO, Ashri AF, Alghamdi JS, Aljehani MK · Aesthetic Plastic Surgery 50(9):3069-3082, 2026 · A systematic review and meta-analysis of 14 studies (3,213 patients, mostly women) of forehead reduction / hairline-lowering surgery. Almost all included studies are retrospective case series, and heterogeneity was very high (I2 92%). Abstract only. Authors declare no conflict of interest.

  • 14 studies, 3,213 patients, mostly women. “Fourteen studies involving 3,213 patients were included; most were female and aged 16-76.”
  • Overall complication rate was about 6%. “The pooled overall complication rate was 5.9% (95% CI, 3.2-10.7%; I2 = 92.4%).”
  • Temporary numbness was nearly universal; 1.2% later had a hair transplant. “temporary paresthesia in 97.3%, subsequent hair transplantation in 1.2%”
  • Reported satisfaction was 99.9%. “Patient satisfaction was exceptionally high at 99.9%”

[14] WOMEN'S Rogaine Unscented (minoxidil 5% topical foam): Drug Facts label

Kenvue Brands / Johnson & Johnson Consumer Inc. · DailyMed (US National Library of Medicine), label version 6, effective Nov 2024, 2024 · The US over-the-counter Drug Facts label of the brand-name 5% minoxidil foam for women. A label states approved use and warnings; it is not a study. Copied from the minoxidil-guide archive (source 3 there, fetched 2026-10-17 from the DailyMed SPL XML); made by the manufacturer.

  • The women's foam is labelled to regrow hair on the top of the scalp. “Hair regrowth treatment for women”
  • It is applied once daily, half a capful. “apply half a capful once daily directly to the scalp in the hair loss area”
  • Results may take 3 months, and at least 6 months for some women. “Results may occur at 3 months with once daily use. For some women, you may need to use this product once a day for at least 6 months before you see results.”
  • Not to be used for sudden or patchy loss, loss after childbirth, or loss of unknown cause. “you do not know the reason for your hair loss”

[15] PROPECIA (finasteride) tablets: US prescribing information

Organon LLC · DailyMed (US National Library of Medicine), label version 9, published Oct 2024 (text revised 11/2023), 2024 · The US prescribing information for Propecia (finasteride 1 mg), written by the manufacturer and approved by the FDA. It is a label, not a study; the one women's trial it cites was in postmenopausal women.

  • Finasteride (Propecia) is not approved for women. “PROPECIA is not indicated for use in women.”
  • It is contraindicated in women who are or may become pregnant, because it can cause genital abnormalities in a male fetus. “Finasteride use is contraindicated in women when they are or may potentially be pregnant.”
  • Pregnant women should not even handle crushed or broken tablets. “Women should not handle crushed or broken PROPECIA tablets when they are pregnant or may potentially be pregnant due to potential risk to a male fetus”
  • In a 12-month trial in 137 postmenopausal women, it did not work better than placebo. “In a study involving 137 postmenopausal women with androgenetic alopecia who were treated with PROPECIA (n=67) or placebo (n=70) for 12 months, effectiveness could not be demonstrated.”

How this page was made

The medical part quotes the sources above, copied from archived pages and papers. The patient part comes from our per-person summaries of reddit threads about the doctors in our directory: a woman counts only when she said she is a woman and her summary says so too. Left out: eyebrow transplants, other operations, and wives writing about their husband’s transplant. Prices and graft counts are as each woman stated them; we don’t average prices, because they differ by country and rise over time.

SaveMyHairline is an independent hair transplant doctor directory: published prices, checked credentials and real patient reports, with sources — and no clinic can pay to appear.